Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

35.90
Delayed Data
As of Sep 20
 +0.20 / +0.56%
Today’s Change
29.95
Today|||52-Week Range
58.95
+11.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues68.4M72.9M69.3M70.9M
 
 
 
 
 
Cost of Goods Sold39.9M20.4M21.5M20.1M
 
 
 
 
 
Depreciation And Amortization3.3M3.3M3.1M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income25.2M49.3M44.7M47.1M
 
 
 
 
 
General Expenses46.2M51.7M58.8M58.4M
 
 
 
 
 
Research And Development9.8M17.1M16.6M18.9M
 
 
 
 
 
Total Operating Expenses89.3M75.4M83.3M82.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.0M-2.5M-14.1M-11.3M
 
 
 
 
 
Extraordinary Credit100.0K0.000.000.00
 
 
Extraordinary Charge0.000.00-3.7M-4.5M
 
 
 
Interest Expense On Debt2.1M2.1M2.8M5.4M
 
 
 
 
 
Other Expenses-8.0K-75.0K10.0K80.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.1M-4.0M-19.8M-19.7M
 
 
 
 
 
Income Taxes-36.0K-21.0K-30.0K-30.0K
 
 
 
 
 
Net Income-22.2M-4.0M-19.9M-19.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.3M37.4M38.0M40.2M
 
 
 
 
 
Shares To Calculate EPS Diluted37.3M37.4M38.0M40.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.59-$0.11-$0.52-$0.49
 
 
 
 
 
EPS Diluted-$0.59-$0.11-$0.52-$0.49